Investigation of Cardinal Health, Inc.
Cardinal Health, Inc. (CAH) Forced to Pay $86 Million in Penalties In August 2005, Cardinal Health, Inc. (CAH) learned in discussions with DEA officials that it was distributing excessive amounts
Cardinal Health, Inc. (CAH) Forced to Pay $86 Million in Penalties In August 2005, Cardinal Health, Inc. (CAH) learned in discussions with DEA officials that it was distributing excessive amounts
Cardinal Health, Inc. (CAH) Forced to Pay $86 Million in Penalties In August 2005, Cardinal Health, Inc. (CAH) learned in discussions with DEA officials that it was distributing excessive amounts
Aurora Cannabis Inc. (ACB) Accused of Misleading Shareholders According to the complaint for alleged violations of the Securities Exchange Act of 1934 between October 23, 2018 and January 6, 2020,
Tufin Software Technologies Ltd. (TUFN) Slashes its Revenue Guidance On January 9, 2020, Tufin Software Technologies Ltd. (TUFN) revealed in its preliminary fourth quarter and fiscal year 2019 results that
Nektar Therapeutics (NKTR) Accused of Misrepresenting the Viability of its Drug NKTR-214 According to the complaint, Nektar touted to investors that NKTR-214 was a promising new universal cancer treatment drug.
Nektar Therapeutics (NKTR) Accused of Misrepresenting the Viability of its Drug NKTR-214 According to the complaint against the company’s officers and directors for alleged breaches of their fiduciary duties, unjust
Year in Review Stocks had a big end of the year jump and investors came out on top despite the ongoing trade war and Federal Reserve halting rate cuts. While
Covetrus, Inc. (CVET) Accused of Misleading Shareholders According to the complaint for alleged violations of the Securities Exchange Act of 1934 between February 8, 2019 and August 12, 2019, on
Health Insurance Innovations, Inc. (HIIQ) Accused of Misleading Investors According to the complaint for alleged breaches of fiduciary duties and gross mismanagement, Health Insurance Innovation, Inc. (HIIQ) filed its
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.